Bevacizumab and interferon-α in metastatic renal-cell carcinoma

被引：0
|
作者：
Ronald M. Bukowski
机构：
[1] Cleveland Clinic Lerner College of Medicine,
[2] Case Western Reserve University,undefined
来源：
Nature Reviews Clinical Oncology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Rini and colleagues provide additional data on bevacizumab and interferon-α in clear-cell carcinoma of the kidney; a comparison of these results with the findings from contemporary trials suggests that bevacizumab and interferon-α is another clinically useful treatment option for patients with metastatic renal-cell carcinoma.
引用
收藏
页码：253 / 254
页数：1
相关论文
共 50 条
  • [1] Bevacizumab and interferon-α in metastatic renal-cell carcinoma
    Bukowski, Ronald M.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 253 - 254
  • [2] INTERFERON THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    SWANSON, DA
    QUESADA, JR
    SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (03): : 174 - 177
  • [3] RECOMBINANT INTERFERON GAMMA IN METASTATIC RENAL-CELL CARCINOMA
    DOBERAUER, C
    LEBER, H
    SCHOMACHER, H
    AKTUELLE UROLOGIE, 1991, 22 (01) : 26 - 29
  • [4] Sunitinib versus interferon - alfa in metastatic renal-cell carcinoma
    Irani, Jacques
    PROGRES EN UROLOGIE, 2007, 17 (05): : 996 - 996
  • [5] INTERFERON ALTERNATING WITH CHEMOTHERAPY FOR PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    DEXEUS, FH
    LOGOTHETIS, CJ
    SELLA, A
    FINN, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (04): : 350 - 354
  • [6] Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
    Motzer, Robert J.
    Hutson, Thomas E.
    Tomczak, Piotr
    Michaelson, M. Dror
    Bukowski, Ronald M.
    Rixe, Olivier
    Oudard, Stephane
    Negrier, Sylvie
    Szczylik, Cezary
    Kim, Sindy T.
    Chen, Isan
    Bycott, Paul W.
    Baum, Charles M.
    Figlin, Robert A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02): : 115 - 124
  • [7] Bevacizumab plus interferon α in patients with metastatic renal cell carcinoma
    Twardowski, Przemyslaw
    Figlin, Robert A.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (08): : 436 - 437
  • [8] INTERFERON-ALPHA THERAPY FOR METASTATIC RENAL-CELL CARCINOMA
    GROSS, AJ
    DIECKMANN, KP
    KRAIN, J
    HULAND, H
    UROLOGE-AUSGABE A, 1995, 34 (02): : 158 - 161
  • [9] Bevacizumab plus interferon α in patients with metastatic renal cell carcinoma
    Przemyslaw Twardowski
    Robert A Figlin
    Nature Clinical Practice Oncology, 2008, 5 : 436 - 437
  • [10] Modest effect of interferon alfa on metastatic renal-cell carcinoma
    Amato, R
    LANCET, 1999, 353 (9146): : 6 - 7
12345